Клиническое исследование

Комбинированная терапия с использованием Durvalumаба и Гистотрипсии для лечения внутрипеченочного хolangiocarcinoma

NCT: NCT07766187 · NOT_YET_RECRUITING

NCT IDNCT07766187

СтатусNOT_YET_RECRUITING

SponsorUniversity of Wisconsin, Madison (OTHER)

First posted2026-08-14

Last updated2026-09-29

Краткое описание

The purpose of this research is to evaluate whether adding histotripsy to maintenance durvalumab increases immune response and to assess the safety of this combination for participants with advanced intrahepatic cholangiocarcinoma (iCCA). Histotripsy is a non-invasive, non-thermal treatment that uses focused ultrasound energy to destroy tumor tissue. 12 people will be enrolled in this study.

Официальный источник

Открыть на ClinicalTrials.gov →

Данные получены через API ClinicalTrials.gov. Актуальный статус смотрите в официальной записи.